DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Randomized Controlled Trial of Three Vasectomy Techniques

Information source: FHI 360
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Contraception

Intervention: Vasectomy occlusion techniques (Procedure)

Phase: N/A

Status: Terminated

Sponsored by: FHI 360

Official(s) and/or principal investigator(s):
Chander Shekhar, MD, Principal Investigator, Affiliation: ICMR
David C. Sokal, MD, Principal Investigator, Affiliation: FHI 360

Summary

This study will be a randomized, controlled multicenter trial, conducted jointly by the Indian Council of Medical Research, New Delhi and Family Health International, which will compare three vasectomy occlusion techniques, all using the no-scalpel vasectomy (NSV) approach to isolation of the vas: 1. ligation and excision of about 1 cm of the vas, with fascial interposition; 2. intraluminal thermal cautery with excision of about 1 cm of the vas; 3. intraluminal thermal cautery with excision of about 1 cm of the vas combined with fascial interposition. A total of 1500 healthy, sexually active men at least 21 years old who have chosen vasectomy as a means of contraception will be recruited at four to six study sites in India. The success of the vasectomy procedure will be determined based on semen analysis results. All men should have semen analyses at 8 and 12 weeks post-vasectomy. All men will be asked to attend a final visit at 12 months.

Clinical Details

Official title: A Randomized Controlled Trial of Three Vasectomy Techniques

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome: Sperm concentration in semen

Secondary outcome: Safety

Detailed description: This study will be a randomized, controlled multicenter trial, conducted jointly by the Indian Council of Medical Research, New Delhi and Family Health International, which will compare three vasectomy occlusion techniques, all using the no-scalpel vasectomy (NSV) approach to isolation of the vas: 1. ligation and excision of about 1 cm of the vas, with fascial interposition; 2. intraluminal thermal cautery with excision of about 1 cm of the vas; and, 3. intraluminal thermal cautery with excision of about 1 cm of the vas combined with fascial interposition. A total of 1500 healthy, sexually active men at least 21 years old who have chosen vasectomy as a means of contraception will be recruited at four to six study sites in India. The success of the vasectomy procedure will be determined based on semen analysis results. All men should have semen analyses at 8 and 12 weeks post-vasectomy. All men will be asked to attend a final visit at 12 months.

Eligibility

Minimum age: 21 Years. Maximum age: N/A. Gender(s): Male.

Criteria:

Inclusion Criteria: 1. Freely consent to participate in the study and sign an informed consent form 2. Be at least 21 years old 3. The couple should have at least one living child greater than one year of age 4. With his partner be willing to use an alternate method of contraception until success is confirmed 5. Be willing to return for follow-up visits at 1, 8, 12 and 52 weeks post-vasectomy, and at 16, 20 and 24 weeks if needed 6. Be willing to submit semen samples collected by masturbation in the clinic according to the study follow-up schedule 7. Be able to understand the procedures and study requirements Exclusion Criteria: 1. Has a condition that in the opinion of the investigator permanently or temporarily contraindicates participation in the study, e. g., depression or poorly-controlled diabetes 2. History of surgery involving the vas or testes (including previous vasectomy) 3. Previous injury or significant abnormality of the scrotum 4. Clinical evidence of an acute sexually transmitted infection; however a man may be admitted to the study after resolution of the acute condition. 5. Local genital infections such as balanitis, scrotal skin infection, epididymitis, or orchitis, but a man may be admitted after resolution of an acute infection 6. History of coagulation or other bleeding disorders 7. Large varicocele, hydrocele, filariasis or elephantiasis of scrotum, or intrascrotal mass 8. Acute systemic infection (including gastroenteritis), but a man may be admitted after resolution of the condition 9. Currently taking or planning to take any type of systemic medication which could affect sperm count (e. g. anabolic steroids)

Locations and Contacts

Maulana Azad Medical College, New Delhi, Delhi 110 002, India

St. Stephens Hospital, New Delhi, Delhi 110 054, India

Post Graduate Institute of Medical Sciences, Rohtak, Haryana 124 001, India

Civil Hospital,, Amritsar, Punjab 143 001, India

E. S.T.N.M. Hospital, Gangtok, Gangtok, Sikkim 737 101, India

Additional Information

Starting date: January 2009
Last updated: September 9, 2013

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017